ferric maltol 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
5076 33725-54-1

Description:

MoleculeDescription

Synonyms:

  • ST10
  • ST10-021
  • accrufer
  • ferric maltol
  • feraccru
potential use as an oral therapy for iron deficiency anemia
  • Molecular weight: 431.15
  • Formula: C18H15FeO9
  • CLOGP:
  • LIPINSKI: None
  • HAC: None
  • HDO: None
  • TPSA: 157.80
  • ALOGS:
  • ROTB: None

Drug dosage:

DoseUnitRoute
60 mg O

ADMET properties:

None

Approvals:

DateAgencyCompanyOrphan
Feb. 18, 2016 EMA
July 25, 2019 FDA SHIELD TX UK LTD

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC B03AB10 BLOOD AND BLOOD FORMING ORGANS
ANTIANEMIC PREPARATIONS
IRON PREPARATIONS
Iron trivalent, oral preparations
MeSH PA D006397 Hematinics
MeSH PA D006401 Hematologic Agents

Drug Use (View source of the data)

DiseaseRelationSNOMED_IDDOID
Iron deficiency anemia indication 87522002
Iron overload contraindication 60737008
Hemochromatosis contraindication 399187006 DOID:2352




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRoutePatent numberPatent expiration datePatent use
30MG IRON ACCRUFER SHIELD TX N212320 July 25, 2019 RX CAPSULE ORAL 9248148 March 29, 2031 METHOD OF TREATING IRON DEFICIENCY
30MG IRON ACCRUFER SHIELD TX N212320 July 25, 2019 RX CAPSULE ORAL 10179120 Jan. 6, 2035 METHOD OF TREATING IRON DEFICIENCY
30MG IRON ACCRUFER SHIELD TX N212320 July 25, 2019 RX CAPSULE ORAL 9802973 Oct. 23, 2035 METHOD OF TREATING IRON DEFICIENCY

Orange Book exclusivity data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRouteExclusivity dateDescription
30MG IRON ACCRUFER SHIELD TX N212320 July 25, 2019 RX CAPSULE ORAL July 25, 2024 NEW CHEMICAL ENTITY

Bioactivity Summary:

None

External reference:

IDSource
CHEMBL4298110 ChEMBL_ID
D10833 KEGG_DRUG
C062088 MESH_SUPPLEMENTAL_RECORD_UI
9974 INN_ID
DB15598 DRUGBANK_ID
MA10QYF1Z0 UNII
169535 PUBCHEM_CID
2539932 RXNORM
31631 MMSL
349513 MMSL
d08432 MMSL
C0060237 UMLSCUI
017087 NDDF

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
ACCRUFER HUMAN PRESCRIPTION DRUG LABEL 1 73059-001 CAPSULE 30 mg ORAL NDA 18 sections
ACCRUFER HUMAN PRESCRIPTION DRUG LABEL 1 73059-001 CAPSULE 30 mg ORAL NDA 18 sections